Michael J. Tocci

Statistics

Publications

Citations

H-Index

Active since

1979

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sanofi (United States)

National Institutes of Health

Sanofi (France)

National Heart Lung and Blood Institute

Michael J. Tocci is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and cytokine biology.

Publications per year

1979–2011

Publications

A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay et al. · Nature · 1992 · 2.6K citations

Life Sciences, Immunology, Molecular Biology +12

FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

Stephen J. O’Keefe, Jun‐ichi Tamura, Randall L. Kincaid et al. · Nature · 1992 · 856 citations

Life Sciences, Cell Biology, Molecular Biology +14

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Michael J. Tocci, D A Matkovich, Kathy Collier et al. · The Journal of Immunology · 1989 · 670 citations

Life Sciences, Immunology, Pharmacology +16

Identification of a monocyte specific pre-interleukin 1 beta convertase activity.

Matthew J. Kostura, Michael J. Tocci, G Limjuco et al. · Proceedings of the National Academy of Sciences · 1989 · 512 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression.

Karen L. MacNaul, Nicole Chartrain, Michael W. Lark et al. · Journal of Biological Chemistry · 1990 · 404 citations · Full text

Medicine, Immunology, Pathology +16

1–5 of 31